Integrated Alzheimer's Disease Treatment and Monitoring System

The present invention integrates cutting-edge technologies, including AI, IoT, blockchain, and machine learning, with the original patented aluminum salt-based treatment for Alzheimer's disease to create a comprehensive system for prevention, treatment, and monitoring of the disease.

Alzheimer's disease is a complex and debilitating condition with limited treatment options. The original patented method using aluminum salts has shown promise, but it has limitations in terms of monitoring patient response and detecting potential adverse reactions. The present invention addresses these limitations by incorporating advanced technologies to create a more effective and personalized treatment approach.

The system comprises multiple modules, including a neural network module for analyzing medical imaging data to identify β-amyloid deposition patterns, a blockchain-based data storage module for secure storage of patient data, an IoT-enabled sensor for monitoring patient vital signs, and a machine learning module for analyzing patient genetic data and medical history to predict optimal treatment regimens. The system also includes a wearable device with an integrated AI-powered algorithm for analyzing patient activity patterns and a cloud-based data analytics module for identifying trends and predicting disease progression. Additionally, the system incorporates a 3D printing module for creating customized pharmaceutical formulations.

The integration of AI, IoT, blockchain, and machine learning technologies with the original patented aluminum salt-based treatment is novel and non-obvious. The use of these technologies enables real-time monitoring, personalized treatment, and secure data storage, which is not possible with the original patented method.

Alternative embodiments of the inventive concept could include the use of different machine learning algorithms, varying IoT sensor configurations, or alternative blockchain platforms. Additionally, the system could be adapted for use in treating other neurodegenerative diseases or expanded to include additional features, such as virtual reality-based therapy modules.

The integrated Alzheimer's disease treatment and monitoring system has significant commercial potential in the healthcare industry, particularly in the areas of personalized medicine, disease monitoring, and digital health. The system could be marketed to pharmaceutical companies, healthcare providers, and medical research institutions, offering a comprehensive solution for Alzheimer's disease treatment and management.